The Secretary of State for the Department for Environment, Food and Rural Affairs (Defra), with the consent of Scottish and Welsh Ministers, has made a decision on a transitional application for authorisation, submitted by Ortho-Clinical Diagnostics, for the time-limited use of a substance of very high concern (SVHC) under UK REACH.
The Defra Secretary of State has granted authorisation to Ortho-Clinical Diagnostics for the following use of a substance:
Formulation of 4-(1,1,3,3-Tetramethylbutyl) phenol, ethoxylated (Triton X-100) for use in the manufacture of in vitro diagnostic VITROS® products used for infectious disease screening, endocrinology, and oncology testing.
This authorisation decision was made under Article 127G which relates to a transitional measure of UK REACH.
Transitional applications received by the Defra Secretary of State are published on GOV.UK.
Decisions made by the Defra Secretary of State are published on GOV.UK.
HSE, 17 August 2021